Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Elisabeth Dignan"'
Publikováno v:
Clinical Cancer Research. 23:B07-B07
Despite recent advances, melanoma remains the deadliest form of skin cancer, and new therapeutic strategies are urgently needed. The MAP kinase (MAPK) and PI3K/AKT pathways are central to both disease progression and chemoresistance in melanoma, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec2de20dd17b1be11bd9837b92e2723a
https://doi.org/10.1158/1557-3265.pmccavuln16-b07
https://doi.org/10.1158/1557-3265.pmccavuln16-b07
Autor:
Elizabeth Kong, Elisabeth Dignan, Philip W. Hinds, Volkan Gunduz, Miriam Enos, Jodie R. Pietruska
Publikováno v:
Molecular Cancer Research. 14:B04-B04
Osteosarcoma, prevalently a pediatric disease, is the most common primary non-hematologic bone tumor. The five-year survival rates range from 24-62% depending on age. A deeper understanding of the disease and new therapeutic approaches are crucial to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84050190ccf1845f0ba701e2223b7dfd
https://doi.org/10.1158/1557-3125.cellcycle16-b04
https://doi.org/10.1158/1557-3125.cellcycle16-b04